With the OVA-sensitized BALB/c mouse model, Vissers et al. found that, the relief of airway hyperresponsiveness following the reduction of EOS after immunotherapy was inhibited through knockout of IL-10 receptor, which corresponded to the decrease of specific IgE and Th2-type cytokine [12]. Here, IGHE is linked to airway hyperresponsiveness.